activity of 129 single-agent drugs in 228 phase i and ii clinical trials in multiple myeloma：多发性骨髓瘤228期临床试验中129个单药药物的活性.pdfVIP

Original Study Activity of 129 Single-Agent Drugs in 228 Phase I and II Clinical Trials in Multiple Myeloma K. Martin Kortuem,1 Kaitlyn Zidich,1 Steven R. Schuster,1 Meaghan L. Khan,1 Victor H. Jimenez-Zepeda,2 Joseph R. Mikhael, 1 Rafael Fonseca,1 A. Keith Stewart 1 Abstract This is the first comparative analysis of single-agent drug activity in multiple myeloma. Our work suggests that a cutoff of 22% single-agent best-reported p